Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.

EBioMedicine - 1 Jul 2017

Binothman Najat, Hachim Ibrahim Y, Lebrun Jean-Jacques, Ali Suhad

Abstract excerpt

Breast cancer represents a major health challenge. The majority of breast cancer deaths are due to cancer progression/recurrence for which no efficient therapies exist. Aggressive breast cancers are characterized by loss of cellular differentiation. Defining molecular mechanisms/targets contributing to cancer aggressiveness is needed to guide the design of new screening and targeted treatments. Here, we describe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Gene Knockdown Techniques
Share to Heterografts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization

Share to mRNA Cleavage and Polyadenylation Factors

Share to Prolactin

Share to RNA-Binding Proteins

Share to RNA Editing

Source

Open in PubMed Open full text

Identifiers

PMID: 28673861
DOI: 10.1016/j.ebiom.2017.06.023
PMCID: PMC5514498

Genes

CPSF6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.PMID 28673861Read ↗

ADAR1 editing dependency in triple-negative breast cancerSemantic proximity Read ↗

A comprehensive investigation of m <sup>6</sup> A regulators prognostic value and associated molecular pathways in breast invasive cancerSemantic proximity Read ↗

Antisense lncRNA transcription promotes A-to-I RNA editing via intermolecular dsRNA in breast cancerSemantic proximity Read ↗

Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinasesSemantic proximity Read ↗

Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3BSemantic proximity Read ↗

Poly(ADP-ribosyl)ation associated changes in CTCF-chromatin binding and gene expression in breast cellsSemantic proximity Read ↗

Inherited blood cancer predisposition through altered transcription elongationSemantic proximity Read ↗

Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast CancerSemantic proximity Read ↗

The implication of the SUMOylation pathway in breast cancer pathogenesis and treatmentSemantic proximity Read ↗

Targeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer TherapiesSemantic proximity Read ↗

Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast CancerSemantic proximity Read ↗

CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone processingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.